iTeos Therapeutics Presents Data from First-in-Human Study of A2A Receptor Antagonist at AACR Virtual Annual Meeting 2020

NEXT STORY
Statement re Impact of Covid-19
PREV STORY
Hua Medicine Announces Positive Results of the Combination Study of Dorzagliatin with Empagliflozin (a SGLT-2 inhibitor)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Project HOPE Celebrates Record Setting Heart Surgery on Newborn in China

MILLWOOD, MD., Feb. 7, 2017 (GLOBE NEWSWIRE) -- Project HOPE says a baby boy ...

author_avatar
NASDAQ Market News

Global Pediatric Imaging Market to Reach $11 Billion by 2027

author_avatar
NASDAQ Market News

Gemphire to Host Expert Panel Call to Discuss Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) and NASH

LIVONIA, Mich., Feb. 21, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage ...

Andrew Matthius
Andrew Matthius